None listed
Conditions
Interventions
None listed
Sponsors
Asan Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Men or Women aged 19 and over 2. Subject who have been diagnosed with aortic valve stenosis disease by cardiac ultrasonography from IRB approval planned percutaneous or surgical aortic valve replacement.
Exclusion criteria
Exclusion criteria: In case of refuze of study paricipaint and collect of human objects in blood samples.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Death of all causes after aortic valve replacement. | — |
Secondary
| Measure | Time frame |
|---|---|
| Heart death, Myocardial infarction, Stroke and transient ischemic attack, Bleeding, Vascular treatment or Operation and associated complications, Acute kidney disease, Insert pacemaker, Complications from other percutaneous aortic valve replacements, Artificial valve failure, Structural abnormality of cardiac valve, NYHA rated at 30 Days after valve replacement/1 Year, 30 days/1 year valve area after valve replacement, Atrial fibrillation | — |
Countries
Korea, Republic of
Contacts
Public ContactJin-hee Won
Asan Medical Center
Outcome results
None listed